Opinions
Benj Gallander
LAB International
LAB-T
WEAK BUY
Nov 13, 2003
Down 13% year-to-date and 8% on a 52-week basis. Did some acquisitions in October. Revenues have been flat year on year. Not much margin. Volume can be thin. Looks like it has made a turn. Risky.
$1.210
Stock price when the opinion was issued
biotechnology
pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
Advertising